Obiettivo
Hantaviruses are health threatening infectious agents causing hemorrhagic fevers with renal syndrome in humans. In Europe, the hantaviruses Pamela and Do Brava have been identified as the main pathogens. There is an urgent need for a development of a bivalent vaccine protecting occupational risk groups and inhabitants of hyper endemic regions against infections by these two viruses.
Campo scientifico
Invito a presentare proposte
Data not availableMeccanismo di finanziamento
CSC - Cost-sharing contractsCoordinatore
10117 Berlin
Germania